Norman C. Selby, Vice Chairman
Norman C. Selby has spent over 40 years in the healthcare industry in a variety of consulting, managerial, investor and Board roles. He is a co-Founder of Real Endpoints. In addition he is an active advisor to two other companies in the healthcare information and IT industries: Rhino Health, one of the leaders in healthcare AI and federated learning, and Jasper, a digital health app for cancer patients.
In the past 20 years Mr. Selby has served as one of the co-Founders of Paige.AI, the CEO of TransForm Pharmaceuticals, Executive Chairman of Windhover Information, Founder and Executive Chairman of Physicians Interactive Holdings, and Board member of Millennium Pharmaceuticals (MLNM) and Infinity Pharmaceuticals (INFI).
Mr. Selby spent the bulk of his early career at McKinsey & Company where he was Director (Senior Partner) in the firm’s New York office, and head of the firm’s Global Pharmaceuticals and Medical Products Practice. From 1987-1989, Mr. Selby took a leave of absence from McKinsey to serve as Chief Operating Officer of the New York Blood Center, the largest community blood organization in the country, where he led its financial and operational turnaround.
Mr. Selby serves on the Board of Trustees of the Central Park Conservancy and the Memorial Sloan-Kettering Cancer Center, and is a member of the Council on Foreign Relations, all based in New York City. He is also on the Advisory Board of the Harvard Business School’s Healthcare Initiative, and until recently was a member of the Board of the National Parks Conservation Association (NPCA), and the honoree at its 2017 Gala.
Mr. Selby holds a B.A. in Architecture from Yale College and an M.B.A. with Distinction from the Harvard Graduate School of Business Administration.